BridgeBio Pharma, Inc. Accrued Liabilities, Current
BridgeBio Pharma, Inc. (BBIO) had Accrued Liabilities, Current of $8.69 million as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2020-11-05
- 2020-09-30: Accrued Liabilities, Current $8.69M.
- 2020-06-30: Accrued Liabilities, Current $11.46M.
- 2020-03-31: Accrued Liabilities, Current $7.46M.
- 2019-12-31: Accrued Liabilities, Current $3.02M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2020-09-30 | $8.69M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.46M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $7.46M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $3.02M 10-Q · filed 2020-11-05 |
| 2019-09-30 | $4.79M 10-Q · filed 2019-11-08 |
| 2018-12-31 | $2.10M 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |